(Q83300907)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16680936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Characterization of an anaphylactoid reaction to omalizumab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16680936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

David H Dreyfus

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16680936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Christopher C Randolph

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16680936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16680936%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16680936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16680936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16680936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

624-627

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16680936%20AND%20SRC:MED&resulttype=core&format=json

Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963560-0

7 January 2021

Monoclonal anti-IgE antibody: a novel therapy for allergic airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963560-0

7 January 2021

Omalizumab is effective in the long-term control of severe allergic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963560-0

7 January 2021

Complications of intravenous immune globulin treatment in neurologic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963560-0

7 January 2021

Intravenous immunoglobulins in neurological disorders: safety issues

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963560-0

7 January 2021

Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963560-0

7 January 2021

Autoimmune skin rashes associated with etanercept for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963560-0

7 January 2021

Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963560-0

7 January 2021

10.1016/S1081-1206(10)63560-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16680936%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference